BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 30338581)

  • 1. Invasive mucormycosis in children with cancer: A retrospective study from the Infection Working Group of Italian Pediatric Hematology Oncology Association.
    Muggeo P; Calore E; Decembrino N; Frenos S; De Leonardis F; Colombini A; Petruzziello F; Perruccio K; Berger M; Burnelli R; Zanazzo GA; Santoro N; Cesaro S
    Mycoses; 2019 Feb; 62(2):165-170. PubMed ID: 30338581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive Mucormycosis in Children With Malignancies: Report From the Infection Working Group of the Hellenic Society of Pediatric Hematology-Oncology.
    Antoniadi K; Iosifidis E; Vasileiou E; Tsipou C; Lialias I; Papakonstantinou E; Kattamis A; Polychronopoulou S; Roilides E; Tragiannidis A
    J Pediatr Hematol Oncol; 2021 Jul; 43(5):176-179. PubMed ID: 32890077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries.
    Pana ZD; Seidel D; Skiada A; Groll AH; Petrikkos G; Cornely OA; Roilides E;
    BMC Infect Dis; 2016 Nov; 16(1):667. PubMed ID: 27832748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucormycosis in hematologic patients.
    Pagano L; Offidani M; Fianchi L; Nosari A; Candoni A; Picardi M; Corvatta L; D'Antonio D; Girmenia C; Martino P; Del Favero A;
    Haematologica; 2004 Feb; 89(2):207-14. PubMed ID: 15003897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
    Riley TT; Muzny CA; Swiatlo E; Legendre DP
    Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
    Lanternier F; Dannaoui E; Morizot G; Elie C; Garcia-Hermoso D; Huerre M; Bitar D; Dromer F; Lortholary O;
    Clin Infect Dis; 2012 Feb; 54 Suppl 1():S35-43. PubMed ID: 22247443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study of mucormycosis in north India: experience from a tertiary care hospital.
    Bala K; Chander J; Handa U; Punia RS; Attri AK
    Med Mycol; 2015 Apr; 53(3):248-57. PubMed ID: 25587084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucormycosis in paediatric patients: demographics, risk factors and outcome of 12 contemporary cases.
    Däbritz J; Attarbaschi A; Tintelnot K; Kollmar N; Kremens B; von Loewenich FD; Schrod L; Schuster F; Wintergerst U; Weig M; Lehrnbecher T; Groll AH
    Mycoses; 2011 Nov; 54(6):e785-8. PubMed ID: 21623951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive cutaneous mucormycosis caused by Absidia corymbifera after allogeneic bone marrow transplantation.
    Jantunen E; Kolho E; Ruutu P; Koukila-Kähkölä P; Virolainen M; Juvonen E; Volin L
    Bone Marrow Transplant; 1996 Jul; 18(1):229-30. PubMed ID: 8832023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucormycosis in Iran: a systematic review.
    Vaezi A; Moazeni M; Rahimi MT; de Hoog S; Badali H
    Mycoses; 2016 Jul; 59(7):402-15. PubMed ID: 26906121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates.
    Guinea J; Escribano P; Vena A; Muñoz P; Martínez-Jiménez MDC; Padilla B; Bouza E
    PLoS One; 2017; 12(6):e0179136. PubMed ID: 28591186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focus on invasive mucormycosis in paediatric haematology oncology patients: a series of 11 cases.
    Phulpin-Weibel A; Rivier A; Leblanc T; Bertrand Y; Chastagner P
    Mycoses; 2013 May; 56(3):236-40. PubMed ID: 23020159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucormycosis at a tertiary-care center in Mexico. A 35-year retrospective study of 214 cases.
    Bonifaz A; Tirado-Sánchez A; Hernández-Medel ML; Araiza J; Kassack JJ; Del Angel-Arenas T; Moisés-Hernández JF; Paredes-Farrera F; Gómez-Apo E; Treviño-Rangel RJ; González GM
    Mycoses; 2021 Apr; 64(4):372-380. PubMed ID: 33253454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of zygomycosis cases by pooled analysis method reported from Turkey].
    Zeka AN; Taşbakan M; Pullukçu H; Sipahi OR; Yamazhan T; Arda B
    Mikrobiyol Bul; 2013 Oct; 47(4):708-16. PubMed ID: 24237440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First Case of Rhinocerebral Mucormycosis Caused by Lichtheimia ornata, with a Review of Lichtheimia Infections.
    Pan J; Tsui C; Li M; Xiao K; de Hoog GS; Verweij PE; Cao Y; Lu H; Jiang Y
    Mycopathologia; 2020 Jun; 185(3):555-567. PubMed ID: 32388712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).
    Salmanton-García J; Seidel D; Koehler P; Mellinghoff SC; Herbrecht R; Klimko N; Ráčil Z; Falces-Romero I; Ingram P; Benítez-Peñuela MÁ; Rodríguez JY; Desoubeaux G; Barać A; García-Vidal C; Hoenigl M; Mehta SR; Cheng MP; Klyasova G; Heinz WJ; Iqbal N; Krause R; Ostermann H; Penack O; Schalk E; Sheppard DC; Willinger B; Wisplinghoff H; Vehreschild JJ; Cornely OA; Vehreschild MJGT;
    J Antimicrob Chemother; 2019 Nov; 74(11):3315-3327. PubMed ID: 31393591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric Mucormycosis: A 10-Year Systematic Review of Reported Cases and Review of the Literature.
    Otto WR; Pahud BA; Yin DE
    J Pediatric Infect Dis Soc; 2019 Sep; 8(4):342-350. PubMed ID: 31181136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucormycosis-A clinicoepidemiological review of cases over 10 years.
    Manesh A; Rupali P; Sullivan MO; Mohanraj P; Rupa V; George B; Michael JS
    Mycoses; 2019 Apr; 62(4):391-398. PubMed ID: 30685896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective antifungal therapy (PATH) alliance(®) : focus on mucormycosis.
    Kontoyiannis DP; Azie N; Franks B; Horn DL
    Mycoses; 2014 Apr; 57(4):240-6. PubMed ID: 24147728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare burden of probable and proven invasive mucormycosis: a multi-centre cost-of-illness analysis of patients treated in tertiary care hospitals between 2003 and 2016.
    Heimann SM; Vehreschild MJGT; Cornely OA; Heinz WJ; Grüner B; Silling G; Kessel J; Seidel D; Vehreschild JJ
    J Hosp Infect; 2019 Mar; 101(3):339-346. PubMed ID: 30423409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.